5/27/20 16:14 | 5/26/20 | FLXN | Health | Drug | Pharmaceutical Preparations | Stejbach Mark | MA | D | | P | 20 | 9.75 | 0 | 2 | 130 | 4 | D | | | | | | | | | | | | | | |
5/27/20 16:11 | 5/26/20 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 100 | 9.75 | 0 | 10 | 1 | 825 | I | | | | | | | | | | | | | | |
8/9/19 16:05 | 8/8/19 | FLXN | Health | Drug | Pharmaceutical Preparations | Colella Samuel D | MA | DT | | P | 21 | 10.74 | 0 | 2 | 0 | 3,997 | I | | | | | | | | | | | | | | |
8/8/19 16:38 | 8/8/19 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 25 | 10.85 | 0 | 2 | 0 | 806 | D | | | | | | | | | | | | | | |
6/3/19 16:18 | 5/31/19 | FLXN | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | P | 28 | 11.05 | 0 | 3 | 3 | 89 | D | | | | | | | | | | | | | | |
5/24/19 09:15 | 5/23/19 | FLXN | Health | Drug | Pharmaceutical Preparations | Merrifield C Ann | MA | D | | P | 101 | 12.64 | 0 | 8 | 400 | 10 | D | | | | | | | | | | | | | | |
5/15/19 16:05 | 5/13/19 | FLXN | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | P | 48 | 11.99 | 0 | 4 | 5 | 87 | D | | | | | | | | | | | | | | |
5/13/19 09:15 | 5/10/19 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 50 | 12.48 | 0 | 4 | 1 | 802 | D | | | | | | | | | | | | | | |
3/13/19 16:11 | 3/12/19 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 50 | 12.36 | 0 | 4 | 1 | 798 | D | | | | | | | | | | | | | | |
11/13/18 09:17 | 11/9/18 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 85 | 17.10 | 0 | 5 | 1 | 797 | M | | | | | | | | | | | | | | |
11/13/18 09:14 | 11/9/18 | FLXN | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | P | 66 | 16.56 | 0 | 4 | 9 | 48 | D | | | | | | | | | | | | | | |
8/10/18 12:56 | 8/9/18 | FLXN | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | P | 94 | 23.42 | 0 | 4 | 10 | 44 | D | | | | | | | | | | | | | | |
8/10/18 09:13 | 8/9/18 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 223 | 22.33 | 0 | 10 | 1 | 783 | D | | | | | | | | | | | | | | |
11/22/17 17:28 | 11/21/17 | FLXN | Health | Drug | Pharmaceutical Preparations | Bodick Neil | MA | O | Chief Sc | P | 66 | 24.49 | 0 | 3 | 1 | 454 | M | | | | | | | | | | | | | | |
11/9/17 09:13 | 11/8/17 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 118 | 23.60 | 0 | 5 | 1 | 743 | D | | | | | | | | | | | | | | |
9/15/17 17:12 | 8/31/17 | FLXN | Health | Drug | Pharmaceutical Preparations | Deniz Yamo | MA | O | Chief Me | P.dm | 132 | 24.48 | 0 | 5 | 148 | 9 | D | | | | | | | | | | | | | | |
6/20/17 16:24 | 6/16/17 | FLXN | Health | Drug | Pharmaceutical Preparations | Stejbach Mark | MA | D | | P | 27 | 17.02 | 0 | 2 | New | 2 | I | | | | | | | | | | | | | | |
6/6/17 18:49 | 6/5/17 | FLXN | Health | Drug | Pharmaceutical Preparations | Colella Samuel D | MA | DT | | P | 85 | 17.01 | 0 | 5 | 0 | 3,995 | I | | | | | | | | | | | | | | |
6/6/17 18:47 | 6/5/17 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 86 | 17.23 | 0 | 5 | 1 | 728 | D | | | | | | | | | | | | | | |
12/5/16 14:40 | 12/1/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Colella Samuel D | MA | DT | | P | 164 | 16.38 | 11 | 10 | 0 | 3,990 | I | 4 | -8 | 5 | 4 | -15 | -19 | -3 | 1 | 4 | 12 | 11 | 19 | | |
11/23/16 20:17 | 11/23/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 31 | 18.41 | 9 | 2 | 0 | 723 | D | 8 | 4 | 57 | 8 | -5 | -3 | -17 | 0 | -1 | -11 | 0 | 4 | | |
11/23/16 08:35 | 11/22/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 30 | 17.95 | 9 | 2 | 0 | 721 | D | 8 | 4 | 57 | 8 | -5 | -3 | -17 | 0 | 3 | -8 | 3 | 7 | | |
11/22/16 18:40 | 11/21/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Colella Samuel D | MA | DT | | P | 600 | 18.00 | 9 | 33 | 1 | 3,980 | I | 4 | 6 | 55 | 0 | -5 | -8 | -17 | -1 | 3 | -4 | 1 | 5 | | |
11/22/16 14:28 | 11/21/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 30 | 17.90 | 9 | 2 | 0 | 719 | D | 4 | 6 | 55 | 0 | -5 | -8 | -17 | -1 | 1 | -3 | 1 | 6 | | |
6/22/16 13:36 | 6/20/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Colella Samuel D | MA | DT | | P.m | 350 | 13.71 | 10 | 26 | 1 | 3,947 | D | -1 | -36 | -28 | 52 | 37 | -18 | 0 | -1 | 0 | 10 | 20 | 24 | 39 | |
6/16/16 17:59 | 6/14/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Merrifield C Ann | MA | D | | P | 13 | 13.39 | 10 | 1 | 100 | 2 | D | 5 | -38 | -30 | 66 | 35 | 20 | -18 | -1 | -5 | -1 | 12 | 16 | 34 | |
6/10/16 21:40 | 6/8/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Lubash Barbara N | CA | T | | P | 10,000 | 14.00 | 9 | 714 | | 409 | I | 11 | -39 | -26 | 44 | 30 | 45 | -20 | -16 | 0 | 1 | 14 | 22 | 37 | |
6/10/16 21:16 | 6/8/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Versant Ventures Iii, LLC | CA | T | | P | 10,000 | 14.00 | 9 | 714 | | 409 | I | 11 | -39 | -26 | 44 | 30 | 45 | -20 | -16 | 0 | 1 | 14 | 22 | 37 | |
6/10/16 20:25 | 6/8/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Colella Samuel D | CA | DT | | P | 10,000 | 14.00 | 9 | 714 | | 409 | I | 11 | -39 | -26 | 44 | 30 | 45 | -20 | -16 | 0 | 1 | 14 | 22 | 37 | |
5/23/16 16:04 | 5/20/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 21 | 10.41 | 2 | 2 | 0 | 706 | D | -16 | -45 | -41 | -4 | -11 | -1 | 11 | 9 | 9 | 47 | 30 | 69 | 71 | |
5/20/16 17:52 | 5/19/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 19 | 9.65 | 2 | 2 | 0 | 704 | D | -23 | -51 | -43 | -11 | -18 | -7 | -4 | 0 | 1 | 70 | 37 | 75 | 79 | |
5/20/16 17:51 | 5/19/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Bodick Neil | MA | O | Chief Me | P | 9 | 10.00 | 2 | 1 | 0 | 465 | D | -23 | -51 | -43 | -11 | -18 | -7 | -4 | 0 | 1 | 70 | 37 | 75 | 79 | |
5/19/16 17:30 | 5/18/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 20 | 10.23 | 2 | 2 | 0 | 702 | D | -19 | -46 | -38 | -14 | -16 | -5 | 1 | 17 | 8 | 17 | 35 | 79 | 104 | |
5/19/16 17:29 | 5/18/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Bodick Neil | MA | O | Chief Me | P | 21 | 10.20 | 2 | 2 | 0 | 464 | D | -19 | -46 | -38 | -14 | -16 | -5 | 1 | 17 | 8 | 17 | 35 | 79 | 104 | |
5/18/16 17:23 | 5/17/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Driscoll Frederick W | MA | O | CFO | P | 25 | 9.87 | 2 | 3 | 42 | 8 | D | -24 | -50 | -44 | -26 | -22 | -10 | -2 | 12 | -5 | 14 | 38 | 78 | 112 | |
5/18/16 17:22 | 5/17/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 19 | 9.73 | 2 | 2 | 0 | 700 | D | -24 | -50 | -44 | -26 | -22 | -10 | -2 | 12 | -5 | 14 | 38 | 78 | 112 | |
5/18/16 17:21 | 5/17/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Bodick Neil | MA | O | Chief Me | P | 8 | 9.60 | 2 | 1 | 0 | 462 | D | -24 | -50 | -44 | -26 | -22 | -10 | -2 | 12 | -5 | 14 | 38 | 78 | 112 | |
5/17/16 18:12 | 5/16/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Driscoll Frederick W | MA | O | CFO | P | 23 | 9.19 | 2 | 3 | 73 | 6 | D | -25 | -48 | -43 | -11 | -12 | -20 | -4 | 3 | 7 | 10 | 43 | 85 | 124 | |
5/17/16 18:10 | 5/16/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 19 | 9.51 | 2 | 2 | 0 | 698 | D | -25 | -48 | -43 | -11 | -12 | -20 | -4 | 3 | 7 | 10 | 43 | 85 | 124 | |
5/17/16 18:08 | 5/16/16 | FLXN | Health | Drug | Pharmaceutical Preparations | Bodick Neil | MA | O | Chief Me | P | 12 | 9.22 | 2 | 1 | 0 | 461 | D | -25 | -48 | -43 | -11 | -12 | -20 | -4 | 3 | 7 | 10 | 43 | 85 | 124 | |
9/14/15 16:32 | 9/11/15 | FLXN | Health | Drug | Pharmaceutical Preparations | Merrifield C Ann | MA | D | | P | 23 | 23.00 | 7 | 1 | New | 1 | D | | 22 | -9 | 6 | 0 | -4 | -5 | -19 | -4 | 2 | -40 | -21 | -63 | -35 |
12/18/14 15:44 | 12/17/14 | FLXN | Health | Drug | Pharmaceutical Preparations | Novo A/s | G7 | T | | P | 8,500 | 17.00 | 2 | 500 | 28 | 2,283 | D | | | 49 | 13 | 8 | 19 | 24 | 11 | 0 | -2 | 10 | 35 | -3 | -8 |
2/20/14 17:11 | 2/18/14 | FLXN | Health | Drug | Pharmaceutical Preparations | Novo A/s | G7 | TH | SEE REMA | P.d | 9,000 | 13.00 | 7 | 692 | 63 | 1,783 | D | | | | | | | | 2 | 4 | 7 | 31 | -15 | -7 | 53 |
2/20/14 15:01 | 2/18/14 | FLXN | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Iii, L.P. | CA | T | | P.d | 4,000 | 13.00 | 7 | 308 | 4 | 8,923 | M | | | | | | | | 2 | 0 | 8 | 31 | -15 | -7 | 54 |
2/20/14 15:00 | 2/18/14 | FLXN | Health | Drug | Pharmaceutical Preparations | Tordjman Rafael | MA | DT | | P.d | 3,000 | 13.00 | 7 | 231 | 12 | 2,105 | I | | | | | | | | 2 | 0 | 8 | 31 | -15 | -7 | 54 |
2/20/14 14:59 | 2/18/14 | FLXN | Health | Drug | Pharmaceutical Preparations | Sofinnova Partners Sas | I0 | T | | P.d | 3,000 | 13.00 | 7 | 231 | 12 | 2,105 | D | | | | | | | | 2 | 0 | 8 | 31 | -15 | -7 | 54 |
2/20/14 14:50 | 2/18/14 | FLXN | Health | Drug | Pharmaceutical Preparations | Colella Samuel D | MA | DT | | P.d | 4,000 | 13.00 | 7 | 308 | 11 | 3,207 | I | | | | | | | | 2 | 0 | 8 | 31 | -15 | -7 | 54 |
2/20/14 14:46 | 2/18/14 | FLXN | Health | Drug | Pharmaceutical Preparations | Bolzon Bradley J Phd | MA | DT | | P.d | 4,000 | 13.00 | 7 | 308 | 11 | 3,207 | I | | | | | | | | 2 | 0 | 8 | 31 | -15 | -7 | 54 |